No overall cost–benefit after RYGB versus SG among T2DM patients
Patients with type 2 diabetes (T2DM) at baseline undergoing RYGB appear to experience a reduced need for ambulatory T2DM monitoring and...
No overall cost–benefit after RYGB versus SG among T2DM patients
Bariatric experts issue recommendations for procedure selection in class I and II obesity patients
Journal Watch 14/2/2024
Gastric bypass improves long-term T2DM remission even after weight recurrence
Intragastric expandable capsule results in clinically meaningful reduction in body weight
BARICO: Bariatric surgery leads to cognitive improvement in approximately 40% of participants
Patients’ perceptions of living with obesity and the prospect of having bariatric surgery